KRRO (STOCKS)
Korro Bio, Inc. Common Stock
$11.760000
-0.530000 (-4.31%)
Prev close: $12.290000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ram Aiyar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $110.75M
- Employees
- 92
- P/E (TTM)
- -1.25
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
7
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.92 | $-2.65 | +0.7259 | +27.43% |
|
Jun 2025 (Q2)
|
$-2.74 | $-2.62 | -0.1243 | -4.75% |
|
Mar 2025 (Q1)
|
$-2.49 | $-2.66 | +0.1654 | +6.23% |
|
Dec 2024 (Q4)
|
$-2.26 | $-2.53 | +0.2696 | +10.66% |
Financial Statements
| Revenues | $7.37M |
| Operating Expenses | $101.87M |
| Research and Development | $71.55M |
| Other Operating Expenses | $30.32M |
| Operating Income/Loss | -$94.50M |
| Income/Loss From Continuing Operations After Tax | -$88.42M |
| Income/Loss From Continuing Operations Before Tax | -$88.31M |
| Income Tax Expense/Benefit | $104.00K |
| Net Income/Loss | -$88.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$88.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$88.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$9.42 |
| Diluted Earnings Per Share | -$9.42 |
| Basic Average Shares | 9,537,634 |
| Diluted Average Shares | 9,537,634 |
| Assets | $161.55M |
| Current Assets | $98.23M |
| Noncurrent Assets | $63.32M |
| Fixed Assets | $24.40M |
| Other Non-current Assets | $38.93M |
| Liabilities | $62.52M |
| Current Liabilities | $14.64M |
| Accounts Payable | $2.30M |
| Other Current Liabilities | $12.34M |
| Noncurrent Liabilities | $47.88M |
| Equity | $99.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $99.03M |
| Liabilities And Equity | $161.55M |
| Net Cash Flow From Operating Activities | -$68.35M |
| Net Cash Flow From Operating Activities, Continuing | -$68.35M |
| Net Cash Flow From Investing Activities | $26.31M |
| Net Cash Flow From Investing Activities, Continuing | $26.31M |
| Net Cash Flow From Financing Activities | $1.24M |
| Net Cash Flow From Financing Activities, Continuing | $1.24M |
| Exchange Gains/Losses | -$15.00K |
| Net Cash Flow | -$40.82M |
| Net Cash Flow, Continuing | -$40.81M |
| Comprehensive Income/Loss | -$88.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$88.78M |
| Other Comprehensive Income/Loss | -$360.00K |